Related Experiment Videos
Borderline hypertension
1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, 48109-0356, USA.
Insights
Borderline hypertension, a common condition, significantly impacts cardiovascular health. Initial management involves nonpharmacologic treatment, with medication considered if blood pressure remains high.
Area of Science:
- Cardiology
- Hypertension Research
- Preventive Medicine
Background:
- Borderline hypertension is prevalent and linked to increased cardiovascular mortality.
- Associated rheologic, hemodynamic, humoral, and metabolic abnormalities contribute to coronary risk.
- Existing literature lacks a clear management and treatment algorithm.
Purpose of the Study:
- To outline a management strategy for borderline hypertension.
- To emphasize the importance of accurate blood pressure assessment.
- To guide therapeutic decisions based on treatment response and patient factors.
Main Methods:
- Establishing a reliable baseline blood pressure using ambulatory or home monitoring.
- Recommending one year of intensive nonpharmacologic treatment as the initial approach.
- Considering pharmacologic treatment with low-dose antihypertensives if nonpharmacologic methods fail.
Main Results:
- Accurate baseline blood pressure measurement is crucial for management.
- Nonpharmacologic treatment is the recommended first-line therapy for one year.
- Pharmacologic intervention is reserved for persistent hypertension, especially with dyslipidemia.
Conclusions:
- A structured approach to borderline hypertension management is necessary.
- Nonpharmacologic interventions should be prioritized.
- Pharmacologic treatment should be carefully considered based on individual patient profiles and treatment outcomes.
Abstract:
Borderline hypertension is a widespread condition and because of its large prevalence, it has a major impact on the cardiovascular mortality of the population. A modest elevation of blood pressure in borderline hypertension is closely associated with multiple rheologic, hemodynamic, humoral and metabolic abnormalities. Many of these abnormalities, independently of the blood pressure, increase the coronary risk in patients with borderline hypertension. There is no sufficient evidence in the literature to propose a well structured algorithm of management and treatment of borderline hypertension. Establishing a reliable baseline blood pressure (by ambulatory or home blood pressure monitoring) is the first step in the management of borderline hypertension. One year of intensive nonpharmacologic treatment is recommended as the first therapeutic modality. If this fails to decrease the blood pressure, pharmacologic treatment with small doses of antihypertensive medication is recommended in patients with dyslipidemia or in patients whose out of office blood pressure remains elevated.